Interestingly, CD62L expression on eosinophils can be triggered by IFNɣ, and CD62L-expressing eosinophils have been suggested to contribute to dysregulated inflammation and ARDS in acute COVID-19 (24, 52). This evidence concerns the gene SELL and COVID-19.